TP53 and carcinoma: It may be that clonal expansion of a cell(s) with a specific TP53 mutation is often a late event (i.e., dysplasia to carcinoma), while isolated aneuploid cells in earlier precursor cell populations sustain distinct TP53 mutations in a majority of those cells that progress toward cancer.